Investing Research

2 Trade Ideas Amidst The Stock Market Whipsaw: $CAT $CINF

Trading in the equity markets has become increasingly more difficult since last summer, ending a series of buying opportunities with deeper corrections in the stock market and more volatility for stocks. While the easy money has been made in the latest bull market, there still remains opportunity for investors on the long side…

Recent Posts

2 Trade Ideas Amidst The Stock Market Whipsaw: $CAT $CINF

Trading in the equity markets has become increasingly more difficult since last summer, ending a series of buying opportunities with deeper corrections in the stock market and more volatility for stocks. While the easy money has been made in the latest bull market, there still remains opportunity for investors on the long side…

LinkedIn Stock Price Crushed: Is More Downside Likely?

LinkedIn Corp (LNKD) has made a name for itself in corporate networking and has a product that many professionals use. However, investors crave growth and innovation. And it seems that one or both may be slowing based on the reaction to LinkedIn’s latest earnings report, which is also seen in…

The Downside Of Corporate Stock Buybacks

“The words of men may temporarily suspend but they do not alter the laws of financial dynamics. The fundamentals always take precedence eventually”- 720 Global on 11/30/2015 The quote above was from “Washington’s Warning” an article that scrutinized stock buybacks and the unforeseen impacts they may have. In that piece…

Stock Market Futures Push Higher; Traders Await Yellen

A positive divergence eventually showed up in price action overnight as stock market futures jumped higher. The S&P 500 futures rose into resistance levels around 1865, which were noted as targets yesterday. I suspect a retest of 1847-1851 at some point. The Morning Report: Stock Market Futures Advance Into Resistance…

Celgene Stock (CELG) Getting Interesting Down Here

In my opinion, Celgene Corp (CELG) may simply be the most compelling biotech company in the world. With the stock down near $100 from $140 less than a year ago, now may be the time to add this biotech marvel to your shopping list. Recent News Celgene’s largest drug is Revlimid…

Stock Market Update: The Selling Continues

The S&P 500 has undercut its January 20 closing low of 1859 and is moving toward the January 20 intraday low of 1812. Concerns continue to center on the banking system’s vulnerability to faulty energy loans and other at-risk debt. And this is weighing on the broad stock market index….

S&P 500 Futures Trading In Jagged Range: Decision Time

S&P 500 futures trading in a jagged range. On Monday, S&P 500 futures drifted into deeper support again before bouncing off a key level near 1838. We hold this level as of this print but charts remain vulnerable to sellers continuing the downward march as long as we sit below…

Stock Market Update: Defensive Sectors Gain In Relative Strength

The stock market indices renewed their downtrend last week with most of the damage occurring in NASDAQ and small-cap issues. And defensive sectors continued to outperform. LinkedIn Corporation (LNKD) fell 44% after a disappointing earnings report. Other tech stocks followed suit after job growth in January was reported weaker than expected….

The COT Report: Traders Show No Love For Tech Stocks

The following is a recap of The COT Report (Commitment Of Traders) released by the CFTC (Commodity Futures Trading Commission) looking at futures positions of non-commercial holdings. This was released within the February 5 COT report (with data through February 2). Note that the change in COT report data is week-over-week. 10…